FindTrial
Sign In

The effect of corticosteroid in twin pregnancy as regard lung maturity

The effect of corticosteroid in twin pregnancy as regard lung maturity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202210545333862
Enrollment
80
Registered
2022-10-25
Start date
2022-09-05
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The effect of corticosteroid in twin pregnancy as regard lung maturity

Interventions

injection of intramuscular corticosteroids
nothing given

Sponsors

october 6 university
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: • Twin pregnancy. • Risk for preterm delivery. • Gestational age: between 24and 38weeks. • Accept to be included in the study. • Maternal age: 18 – 40 years old.

Exclusion criteria

Exclusion criteria: singelton pregnacy with contraindiaction for corticosteroids as DM, severe uncontrolled hypertension, infections

Design outcomes

Primary

MeasureTime frame
1- respiratory distress syndrome occurrence 2- Need for NICU admission. 3- Any other complications.—

Secondary

MeasureTime frame
safety of usage of corticosteroids in enhancing lung maturity by assessment of complications—

Countries

Egypt

Contacts

Public ContactAshraf Sobhi Abolouz

assistant prof obstetrics and gynecology

ashraflouz@yahoo.com00201222376540

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026